NASDAQ:VIR

Vir Biotechnology Stock Predictions

etoro logo Buy VIR
*Your capital is at risk
$8.77
+0.0300 (+0.343%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VIR Prediction Chart

VIR Predictions History

Latest community submissions for VIR.
Predictor Target Session Target Price Result Direction Accuracy Score
Alex Pippen Alex Pippen @AlexPippen.164908
Jun 22, 2020 $37.32 -4.04% $38.89 X 95.96% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VIR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIR BIOTECHNOLOGY, INC.
Vir Biotechnology
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus....
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE